Linear Clinical Research Ltd

Running trials

• Recruiting

  Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  NCT07435038· Phase 1/2· Source

• Enrolling by invitation

  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  NCT06788509· Phase 1· Source

• Recruiting

  A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

  NCT06244771· Phase 1/2· Source

• Recruiting

  Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

  NCT05969041· Phase 1· Source

• Active, not recruiting

  Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)

  NCT05878184· Phase 1· Source

• Active, not recruiting

  A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

  NCT05581004· Phase 1· Source

• Recruiting

  Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  NCT05519449· Phase 1· Source

• Active, not recruiting

  A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

  NCT05424822· Phase 1· Source

• Active, not recruiting

  A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Nivolumab in Patients With NRAS-mutant Advanced Melanoma.

  NCT04835805· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer3 recruiting
• Colorectal cancer2 recruiting
• Pancreatic cancer2 recruiting
• Prostate cancer2 recruiting
• Acute myeloid leukemia1 recruiting
• Cervical cancer1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Gastric and esophageal cancer1 recruiting
• Hodgkin lymphoma1 recruiting
• Myelodysplastic syndromes1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study of TeriQ Patch in Healthy Adult Female Participants

  NCT06644040· Phase 1· Source

• Completed

  A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

  NCT04657224· Phase 1· Source

• Completed

  A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

  NCT04540796· Phase 1· Source

• Terminated

  Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

  NCT04383210· Phase 2· Source

• Completed

  REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

  NCT04526106· Phase 1/2· Source

• Completed

  A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

  NCT03900598· Phase 1· Source